HKU Scholars Hub: Search

Search

Results 1-25 of 71 (Search time: 0.011 seconds).

previous
1
2
3
next

	Title	Author(s)	Issue Date
	Functional Genomic Strategies for Cancer Biology and Precision Cancer Therapy Proceeding/Conference:School of Biomedical Sciences Seminar	Cheung, WTL	2016
	Approaches for functional genomics. Proceeding/Conference:Universitas 21 (U21) Early Career Researcher (ECR) Workshop: Big Data at the heart of 21st Century Research	Cheung, WTL	2016
	Cancer‐associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17 Journal:The FEBS Journal	Srivastava, Y TAN, DS Malik, V WENG, M Javed, A Cojocaru, V Wu, G Veerapandian, V Cheung, LWT Jauch, R	2020
	Gonadotropin-releasing hormone promotes motility and invasiveness of ovarian cancer cells through transactivation of the insulin-like growth factor-1 receptor Proceeding/Conference:Cancer Research	Cheung, WT Leung, PCK Wong, AST	2009
	Pigment Epithelium-Derived Factor, a Gene Down-Regulated by Estrogen, Mediates Growth Inhibition in Human Ovarian Surface Epithelial and Ovarian Cancer Cells Proceeding/Conference:Annual Meeting of the Endocrine Society, ENDO 2006	Cheung, WT Au, SCL Cheung, ANY Ngan, HYS Wong, AST	2006
	GnRH promotes peritoneal adhesion and dissemination of ovarian cancer cells Proceeding/Conference:AACR Meeting Abstracts	Cheung, LWT Leung, PCK Wong, AST	2010
	Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer Journal:Oncogene	Cheung, LWT Leung, PCK Wong, AST	2010
	Cadherin-catenin signaling in ovarian cancer progression Book:Signal transduction in cancer metastasis	Cheung, WT Ip, KM Wong, AST	2010
	Strategic combination therapies for ovarian cancer Journal:Current Cancer Drug Targets	Li, X Ng, ASN Mak, VCY Chan, KKL Cheung, ANY Cheung, LWT	2020
	A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets Journal:Cell Reports	Zhou, P Chan, BKC Wan, YK YUEN, CTL Choi, GCG LI, X Tong, CSW Zhong, SSW Sun, J Bao, Y Mak, SYL Chow, MZY Khaw, JV Leung, SY Zheng, Z Cheung, LWT Tan, K Wong, KH Chan, HYE Wong, ASL	2020
	Targeting AXL in PIK3R2-amplified ovarian cancer Proceeding/Conference:Cancer Research	Rao, L Mak, CY Zhou, Y Zhang, D Li, X Lu, Y Mills, GB Cheung, WTL	2020
	Loss of AKTIP activates ERα signaling in breast cancer Proceeding/Conference:The 25th Research Postgraduate Symposium (RPS), Li Ka Shing Faculty of Medicine, The University of Hong Kong	Ng, SN Cheung, WTL	2020
	Synergistic antitumor activity of HER-TKI and AKT inhibitor in cancer cells with p85α N-terminal SH2 domain oncogenic mutations Proceeding/Conference:Keystone Symposia on Molecular and Cellular Biology: Precision Oncology: Translating Discovery to the Clinic	Lau, YT LI, X NG, SN Zhou, Y Cheung, WTL	2021
	Characterization of PIK3R1 driver aberrations reveals novel therapeutic responses in gynecological cancers. Proceeding/Conference:14th International Symposium on Healthy Aging: Embrace the Golden Years	Li, X Ng, AS Mak, CY Zhou, Y Cheung, ANY Cheung, WTL	2019
	Therapeutic implication of PIK3R2 amplification in ovarian cancer Proceeding/Conference:14th International Symposium on Healthy Aging: Embrace the Golden Years	Rao, L Mak, CY Fung, CC Zhou, Y Cheung, WTL	2019
	p85α alters Gab2 phosphorylation profile in ovarian cancer Proceeding/Conference:Cancer Research	Li, X Mak, VCY Cheung, ANY Mills, GB Cheung, WTL	2019
	Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer Journal:Nature Communications	LI, X Mak, VCY Zhou, Y Wang, C Wong, ESY Sharma, R Lu, Y Cheung, ANY Mills, GB Cheung, LWT	2019
	Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro Journal:BMC Cancer	Aslan, O Cremona, M Morgan, C Cheung, WTL Mills, GB Hennessy, BT	2018
	Systematic Functional Annotation of Somatic Mutations in Cancer Journal:Cancer Cell	Ng, PK Li, J Jeong, KJ Shao, S Chen, H Tsang, YH Sengupta, S Wang, Z Bhavana, VH Tran, R Soewito, S Minussi, DC Moreno, D Kong, K Dogruluk, T Lu, H Gao, J Tokheim, C Zhou, C Johnson, AM Zeng, J Ip, CK Ju, Z Wester, M Yu, S Li, Y Vellano, CP Schultz, N Karchin, R Ding, L Lu, Y Cheung, WTL Chen, K Shaw, K Meric-Bernstam, F Scott, KL Yi, S Sahni, N Liang, H Mills, GB	2018
	PIK3R1 loss activates AKT and STAT3 signaling in ovarian cancer Proceeding/Conference:Cancer Research	Li, X Mak, CY Zhou, Y Lu, Y Cheung, ANY Mills, GB Cheung, WTL	2018
	PIK3R1 loss predicts sensitivity to AKT and STAT3 inhibitors in ovarian cancer Proceeding/Conference:Hong Kong Inter-University Postgraduate Symposium in Biochemical Sciences	Li, X Mak, CY Cheung, ANY Cheung, WTL	2018
	Targeting PIK3R1 loss by AKT and STAT3 inhibitors in ovarian cancer Proceeding/Conference:13th International Symposium on Healthy Aging	LI, X Mak, CY Cheung, ANY Cheung, WTL	2018
	The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours Journal:The Lancet Regional Health - Western Pacific	El Helali, A Lam, TC Ko, EYL Shih, DJH Chan, CK Wong, CHL Wong, JWH Cheung, LWT Lau, JKS Liu, APY Chan, ASY Loong, HH Lam, STS Chan, GCF Lee, VHF Yuen, KK Ng, WT Lee, AWM Ma, ESK	28-Apr-2023
	AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance Journal:Cell Reports	Ng, ASN Zhang, SB Mak, VCY Zhou, Y Yuen, Y Sharma, R Lu, YL Zhuang, GL Zhao, W Pang, HH Cheung, LWT	13-Dec-2022
	APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis. Journal:British Journal of Cancer	Long, XR Lu, HW Cai, MC Zang, JY Zhang, ZQ Wu, J Liu, XS Cheng, L Cheng, JJ Cheung, LWT Shen, Z Zhou, Y Di, W Zhuang, GL Yin, X	30-Jun-2023